Researchers involved in pain science: fill out this survey to have your say on the priorities to be established within the EFIC Pain Research Strategy.
Abstract submission for our next annual congress is now open! EAN Programme Committee Chair, Prof. Ulf Kallweit shares the details on this and other latest news about EAN 2023.
Our authors of the month report the results of a multicentre phase-3 clinical trial exploring efficacy and safety of Lecanemab in patients with early AD over a follow-up period of eighteen months.
Our authors of the month conducted a retrospective study of the potential association between COVID-19 and seizures or epilepsy in the six months after infection, using an electronic health records network of 81 million people.
The EAN was delighted to welcome 54 participants from 24 countries to Loutraki, Greece, for three days of sea, sunshine and neurology at our 2022 Autumn School.
Our highlighted selection of COVID-19-related meta-analyses and systemic reviews from the scientific press for November 2022. *Note – starting in December 2022 our monthly COVID-19 Breaking News articles will be published under the new name ‘Covid Research Roundup’*
Our pick of COVID-19-related cross-sectional case control studies from the scientific press for November 2022. *Note – starting in December 2022 our monthly COVID-19 Breaking News articles will be published under the new name ‘Covid Research Roundup’*
Our selection of miscellaneous COVID-19-related studies from the scientific press for November 2022.
*Note – starting in December 2022 our monthly COVID-19 Breaking News articles will be published under the new name ‘Covid Research Roundup’*
Our editors' pick of COVID-19-related observational studies from the scientific press for November 2022.
*Note - starting in December 2022 our monthly COVID-19 Breaking News articles will be published under the new name 'Covid Research Roundup'*